"Pancreatic Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).
| Descriptor ID |
D010190
|
| MeSH Number(s) |
C04.588.274.761 C04.588.322.475 C06.301.761 C06.689.667 C19.344.421
|
| Concept/Terms |
Pancreatic Neoplasms- Pancreatic Neoplasms
- Neoplasm, Pancreatic
- Pancreatic Neoplasm
- Pancreas Neoplasms
- Neoplasm, Pancreas
- Neoplasms, Pancreas
- Pancreas Neoplasm
- Neoplasms, Pancreatic
Cancer of Pancreas- Cancer of Pancreas
- Pancreas Cancers
- Pancreas Cancer
- Cancer, Pancreas
- Cancers, Pancreas
- Pancreatic Cancer
- Cancer, Pancreatic
- Cancers, Pancreatic
- Pancreatic Cancers
- Cancer of the Pancreas
|
Below are MeSH descriptors whose meaning is more general than "Pancreatic Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Pancreatic Neoplasms".
This graph shows the total number of publications written about "Pancreatic Neoplasms" by people in this website by year, and whether "Pancreatic Neoplasms" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 8 | 3 | 11 |
| 1996 | 8 | 1 | 9 |
| 1997 | 13 | 3 | 16 |
| 1998 | 15 | 3 | 18 |
| 1999 | 21 | 3 | 24 |
| 2000 | 16 | 4 | 20 |
| 2001 | 12 | 3 | 15 |
| 2002 | 24 | 6 | 30 |
| 2003 | 47 | 5 | 52 |
| 2004 | 30 | 7 | 37 |
| 2005 | 43 | 13 | 56 |
| 2006 | 37 | 9 | 46 |
| 2007 | 58 | 10 | 68 |
| 2008 | 59 | 14 | 73 |
| 2009 | 69 | 13 | 82 |
| 2010 | 78 | 8 | 86 |
| 2011 | 82 | 11 | 93 |
| 2012 | 97 | 12 | 109 |
| 2013 | 112 | 11 | 123 |
| 2014 | 110 | 6 | 116 |
| 2015 | 111 | 16 | 127 |
| 2016 | 125 | 7 | 132 |
| 2017 | 115 | 13 | 128 |
| 2018 | 114 | 10 | 124 |
| 2019 | 121 | 10 | 131 |
| 2020 | 129 | 8 | 137 |
| 2021 | 142 | 6 | 148 |
| 2022 | 101 | 4 | 105 |
| 2023 | 85 | 4 | 89 |
| 2024 | 89 | 10 | 99 |
| 2025 | 5 | 0 | 5 |
Below are the most recent publications written about "Pancreatic Neoplasms" by people in Profiles.
-
Chemotherapy dose density is prognostic for overall survival in patients with resectable pancreas cancer: A landmark analysis of SWOG 1505. Cancer. 2025 Feb 15; 131(4):e35759.
-
Early detection of pancreatic cancer by a high-throughput protease-activated nanosensor assay. Sci Transl Med. 2025 Feb 12; 17(785):eadq3110.
-
Management of Peritoneal Metastasis in Patients with Pancreatic Ductal Adenocarcinoma. Curr Oncol. 2025 Feb 12; 32(2).
-
Tumor-Intrinsic Kinome Landscape of Pancreatic Cancer Reveals New Therapeutic Approaches. Cancer Discov. 2025 Feb 07; 15(2):346-362.
-
Burdens of Gastroenteropancreatic Neuroendocrine Neoplasm by Diverse Race and Ethnicities- A Rigorous Structural Equation Modeling. J Natl Compr Canc Netw. 2025 Feb; 23(2):27-32.
-
Ivermectin Combined With Recombinant Methioninase (rMETase) Synergistically Eradicates MiaPaCa-2 Pancreatic Cancer Cells. Anticancer Res. 2025 Jan; 45(1):97-103.
-
Assessing Large Language Models for Oncology Data Inference From Radiology Reports. JCO Clin Cancer Inform. 2024 Dec; 8:e2400126.
-
Quantification of PD-L1 expression and tumor mutational burden in biologically distinct advanced pancreatic cancers responding to pembrolizumab: case reports. Front Immunol. 2024; 15:1452543.
-
Factors Influencing Immunotherapy Utilization in Stage IV Pancreatic Cancer: Impact of Race and Socioeconomics in the U.S. J Gastrointest Cancer. 2024 Nov 27; 56(1):25.
-
Differential Effects of Confinement on the Dynamics of Normal and Tumor-Derived Pancreatic Ductal Organoids. ACS Appl Bio Mater. 2024 Dec 16; 7(12):8489-8502.